Higher Dose Naloxone Nasal Spray Gets FDA Approval
Kloxxado is intended for immediate administration as emergency therapy in settings where opioids may be present.
Substance Use
Preventive and Chronic Illness Care Poorer Among Individuals With Opioid Use Disorder
The study authors measured the quality of non-opioid use disorder (OUD) preventive and chronic illness care and care coordination for individuals with OUD compared with individuals without OUD.
Younger Age at First Drug Use Tied to Faster Transition to Substance Use Disorder
Younger age at drug initiation is associated with a faster transition to substance use disorder (SUD).
Illicit Stimulant Use Common for Chronic Pain Management in Women With Neuropathic Pain
The researchers sought to evaluate the relationship between pain management and stimulant use in people with chronic pain.
US Overdose Deaths Have Soared During COVID-19 Pandemic
There were more than 87,000 drug overdose deaths in the United States from October 2019 to September 2020.
Patient Navigation Services Lower Readmission in Adults With Substance Use Disorder
For hospitalized adults with comorbid substance use disorders (SUDs), patient navigation services reduce readmissions and emergency department use.
Case Series: Naloxone Use Linked to Acute Pulmonary Edema
At normal doses, the drug’s adverse effects are minimal, with the majority being attributed to acute withdrawal effects.
Symptoms of Depression and Suicidal Ideation Among Adolescents Positively Affected by Increased Parental Monitoring
This study looked at the predictive effects of parenting processes and family functioning on depressive symptoms and suicidal ideation in a randomized controlled trial of integrated cognitive-behavioral therapy vs. treatment as usual for adolescents with comorbid SUDs and psychiatric disorders.
People with Premature Atherosclerotic CVD More Likely to Report High Recreational Substance Use
Researchers studied the links between recreational substance and with premature and extremely premature atherosclerotic cardiovascular diseases (ASCVDs).
Bupropion-Naltrexone More Efficient Than Placebo in Methamphetamine Use Disorder
For adults with methamphetamine use disorder, response is higher with receipt of extended-release injectable naltrexone plus bupropion.
-
Loading...
-
Loading...
Next post in Opioid Addiction
